Evidence map›Paper›PMID 34398952›Full record

SynthesisClinical infectious diseases : an official publication of the Infectious Diseases Society of America2021

A Systematic Review and Network Meta-analyses to Assess the Effectiveness of Human Immunodeficiency Virus (HIV) Self-testing Distribution Strategies.

Ingrid Eshun-Wilson, Muhammad S Jamil, T Charles Witzel, David V Glidded, Cheryl Johnson, Noelle Le Trouneau, Nathan Ford, Kathleen McGee, Chris Kemp, Stefan Baral and 2 more

Abstract readSystematic ReviewNetwork Meta-Analysis
In one paragraph

Synthesis in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Person-centred HIV prevention in an era of innovation and uncertainties.Journal of the International AIDS Society · 2025
    Article
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Ingrid Eshun-WilsonWashington University School of Medicine, St Louis, Missouri, USA.ORCID 0000-0002-4049-9868
Muhammad S JamilGlobal HIV, Hepatitis and STI Programme, World Health Organization, Geneva, Switzerland.
T Charles WitzelDepartment of Public Health, Environments and Society, London School of Hygiene & Tropical Medicine, London, United Kingdom.
David V GliddedDepartment of Epidemiology, University of California, San Francisco, California, USA.
Cheryl JohnsonGlobal HIV, Hepatitis and STI Programme, World Health Organization, Geneva, Switzerland.
Noelle Le TrouneauDepartment of Epidemiology, University of California, San Francisco, California, USA.
Nathan FordGlobal HIV, Hepatitis and STI Programme, World Health Organization, Geneva, Switzerland.
Kathleen McGeeDepartment of Global Health and Development, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Chris KempDepartment of Epidemiology, University of California, San Francisco, California, USA.
Stefan BaralDepartment of Epidemiology, John Hopkins School of Public Health, Baltimore, Maryland, USA.
Sheree SchwartzDepartment of Epidemiology, John Hopkins School of Public Health, Baltimore, Maryland, USA.
Elvin H GengWashington University School of Medicine, St Louis, Missouri, USA.

Funding

Washington University Institute of Clinical and Translational Sciences (KL2) KL2TR002346 · NCATS · WASHINGTON UNIVERSITY · PI Dominic N Reeds · 2017 to 2026
$14.0M
MENTORING MULTIDISCIPLINARY PATIENT-ORIENTED RESEARCH IN ENGAGEMENT IN HIV CAREK24AI134413 · NIAID · WASHINGTON UNIVERSITY · PI Elvin H. Geng · 2017 to 2026
$1.4M
Bill and Melinda Gates Foundation OPP1215984National Institute for Health Research PG-1212-20006NCATS NIH HHS KL2 TR002346NIAID NIH HHS K24 AI134413World Health Organization 001
6 · The paper itself

Abstract

backgroundWe conducted a systematic review and network meta-analysis to identify which human immunodeficiency virus (HIV) self-testing (HIVST) distribution strategies are most effective.

methodsWe abstracted data from randomized controlled trials and observational studies published between 4 June 2006 and 4 June 2019.

resultsWe included 33 studies, yielding 6 HIVST distribution strategies. All distribution strategies increased testing uptake compared to standard testing: in sub-Saharan Africa, partner HIVST distribution ranked highest (78% probability); in North America, Asia, and the Pacific regions, web-based distribution ranked highest (93% probability), and facility based distribution ranked second in all settings. Across HIVST distribution strategies HIV positivity and linkage was similar to standard testing.

conclusionsA range of HIVST distribution strategies are effective in increasing HIV testing. HIVST distribution by sexual partners, web-based distribution, as well as health facility distribution strategies should be considered for implementation to expand the reach of HIV testing services.

Indexed as

HIV InfectionsSelf-TestingHIVHumansMass ScreeningSexual PartnersHIV self-testingimplementationnetwork meta-analysissystematic review

Identifiers

PMID34398952
PMCPMC8366833

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.